<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Fat05spoon</id>
		<title>HistoryPedia - Внесок користувача [uk]</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Fat05spoon"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=%D0%A1%D0%BF%D0%B5%D1%86%D1%96%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0:%D0%92%D0%BD%D0%B5%D1%81%D0%BE%D0%BA/Fat05spoon"/>
		<updated>2026-05-21T03:50:44Z</updated>
		<subtitle>Внесок користувача</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=For_many_years,_antibodies_to_the_V1/V2_domain_were_considered_to_be_too_strain_specific_and_of_little_use_in_vaccines_designed_to_elicit_broad_protective_immunity&amp;diff=118996</id>
		<title>For many years, antibodies to the V1/V2 domain were considered to be too strain specific and of little use in vaccines designed to elicit broad protective immunity</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=For_many_years,_antibodies_to_the_V1/V2_domain_were_considered_to_be_too_strain_specific_and_of_little_use_in_vaccines_designed_to_elicit_broad_protective_immunity&amp;diff=118996"/>
				<updated>2016-11-30T15:42:03Z</updated>
		
		<summary type="html">&lt;p&gt;Fat05spoon: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Whilst deletion of the V2 area enhanced immunogenicity and pressure-particular neutralizing antibodies, it did not boost the development of bNAbs. In 2009, it was identified that a key class of bNAbs in plasma from HIV-contaminated human beings, the PG9 loved ones, was directed to the V1/V2 area and focused GDEs involving PNGS at positions N156 and N160 [20,23]. Subsequently, it was described that the PGT128 household of bNAbs depended on contacts with glycans at N136 in the V1 domain and at N301 and N332 in the stem of the V3 area [eighteen,21,24]. This represented a major progress in knowing the specificity of bNAbs and recommended that prior gp120 vaccines this kind of as the AIDSVAX B/B and AIDSVAX B/E vaccines [sixty,61] utilized in the VAX003, VAX004, and RV144 trials [25,fifty three,62] may be enhanced by incorporation of particular glycan constructions needed for the binding of bN-MAbs these kinds of as PG9, PGT121, and PGT128 [63,sixty four]. In preceding scientific studies [one hundred thirty five] we employed swarm examination to determine 8 polymorphisms in clade B viruses, like 3 mutations in the V2 domain, three in gp41, and two in the CD4 binding website that conferred resistance to neutralization by bNAbs. In the existing reports, we identified a few mutations conferring neutralization resistance from three unbiased infections that all mapped to glycans in the V1 area. This end result elevated the chance that CRF01_AE viruses might have advanced a distinct strategy for immune escape than clade B viruses. This is regular with the observation that CRF01_AE viruses generally lack the N332 glycosylation site required for binding by PGT121-like antibodies, and that this glycan make contact with can not be changed by glycans at 334 as is the case with viruses from other clades [22]. However, further information will be essential to test this speculation. In Fig. 5A, we have threaded the a few V2 mutations that alter neutralization susceptibility in clade B viruses, and the two glycosylation website mutations identified in this review, on to the modern framework of trimeric gp140 [twenty]. Earlier, we noted mutations that transpired at position 167 in the connecting peptide among the B and C strands, at place 179 in the connecting peptide among the C and D strands, and at a glycosylation web site at situation 197 at the stop of the D strand [15]. In this examine, we discovered that the sequences adjacent to the connecting peptide amongst the A and B strands in the same way confer neutralization sensitivity and resistance. Hence the sequences at the ends and uncovered turns of all 4 strands in the V1/V2 area -sheet structure all show up to [http://messaging.im/index.php?do=/blog/101078/nonetheless-the-present-research-supports-prior-observations-that-this-prot/ Nonetheless, the current review supports earlier observations that this protein is particularly susceptible to temporal deregulation] modulate neutralization sensitivity and resistance. The total sample of neutralization sensitivity and resistance that we observed at situation 136 in the V1/V2 domain appears related to the pattern of evolution of neutralization sensitivity and resistance explained by Moore et al. [65] for antibodies focusing on the V3 stem of clade C viruses. In that study, narrowly distinct neutralizing antibodies that regarded the V3 stem have been detected early after an infection. Subsequently the virus developed an N-joined glycosylation website at N332 that permitted the virus to escape neutralization by antibodies with narrow specificity.&lt;/div&gt;</summary>
		<author><name>Fat05spoon</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=For_many_years,_antibodies_to_the_V1/V2_domain_were_considered_to_be_too_strain_specific_and_of_little_use_in_vaccines_designed_to_elicit_broad_protective_immunity&amp;diff=118958</id>
		<title>For many years, antibodies to the V1/V2 domain were considered to be too strain specific and of little use in vaccines designed to elicit broad protective immunity</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=For_many_years,_antibodies_to_the_V1/V2_domain_were_considered_to_be_too_strain_specific_and_of_little_use_in_vaccines_designed_to_elicit_broad_protective_immunity&amp;diff=118958"/>
				<updated>2016-11-30T13:51:35Z</updated>
		
		<summary type="html">&lt;p&gt;Fat05spoon: Створена сторінка: For many several years, antibodies to the V1/V2 area ended up considered to be too pressure specific and of small use in vaccines created to elicit broad protec...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;For many several years, antibodies to the V1/V2 area ended up considered to be too pressure specific and of small use in vaccines created to elicit broad protecting immunity. Later it was reported that the V1/V2 domain is essential for conformational masking and serves to protect important areas of gp120 (e.g. V3 domain and CD4 binding web site) from antibody binding [558]. Certainly, it was proposed that conformational masking by the V1/V2 domain inhibited the development of neutralizing antibodies and that envelope proteins with deleted V2 [http://qq435579638.820.web1268.net/comment/html/?144886.html In the DEKA mutant, the movement of Lys180 side chain is equivalent to the a-technique, with the terminal amino team fairly freely traversing in the SF pore] domains may possibly symbolize improved vaccine immunogens [56,59]. While deletion of the V2 domain enhanced immunogenicity and pressure-specific neutralizing antibodies, it did not boost the formation of bNAbs. In 2009, it was uncovered that a major class of bNAbs in plasma from HIV-infected humans, the PG9 loved ones, was directed to the V1/V2 domain and specific GDEs involving PNGS at positions N156 and N160 [20,23]. Subsequently, it was noted that the PGT128 family of bNAbs depended on contacts with glycans at N136 in the V1 area and at N301 and N332 in the stem of the V3 domain [18,21,24]. This represented a significant progress in comprehending the specificity of bNAbs and recommended that previous gp120 vaccines these kinds of as the AIDSVAX B/B and AIDSVAX B/E vaccines [60,sixty one] utilised in the VAX003, VAX004, and RV144 trials [25,fifty three,62] may possibly be improved by incorporation of certain glycan structures needed for the binding of bN-MAbs such as PG9, PGT121, and PGT128 [63,64]. In preceding research [a hundred thirty five] we utilised swarm investigation to identify eight polymorphisms in clade B viruses, such as a few mutations in the V2 area, a few in gp41, and two in the CD4 binding site that conferred resistance to neutralization by bNAbs. In the present scientific studies, we discovered three mutations conferring neutralization resistance from a few independent bacterial infections that all mapped to glycans in the V1 area. This outcome elevated the likelihood that CRF01_AE viruses could have advanced a various strategy for immune escape than clade B viruses. This is constant with the observation that CRF01_AE viruses generally lack the N332 glycosylation site needed for binding by PGT121-like antibodies, and that this glycan make contact with can not be replaced by glycans at 334 as is the circumstance with viruses from other clades [22]. However, additional info will be needed to check this speculation. In Fig. 5A, we have threaded the 3 V2 mutations that alter neutralization susceptibility in clade B viruses, and the two glycosylation web site mutations discovered in this research, on to the current structure of trimeric gp140 [twenty]. Previously, we reported mutations that transpired at position 167 in the connecting peptide among the B and C strands, at place 179 in the connecting peptide in between the C and D strands, and at a glycosylation internet site at place 197 at the stop of the D strand [15]. In this review, we located that the sequences adjacent to the connecting peptide between the A and B strands equally confer neutralization sensitivity and resistance. Thus the sequences at the finishes and uncovered turns of all four strands in the V1/V2 domain -sheet framework all appear to modulate neutralization sensitivity and resistance.&lt;/div&gt;</summary>
		<author><name>Fat05spoon</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Mutations_at_glycosylation_sites_in_the_V1_domain_of_CRF01_AE_viruses_that_determine_sensitivity_and_resistance_to_neutralization_are_located_at_the_junction_of_the_A_and_B_strands_at_positions_136_and_149&amp;diff=118873</id>
		<title>Mutations at glycosylation sites in the V1 domain of CRF01 AE viruses that determine sensitivity and resistance to neutralization are located at the junction of the A and B strands at positions 136 and 149</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Mutations_at_glycosylation_sites_in_the_V1_domain_of_CRF01_AE_viruses_that_determine_sensitivity_and_resistance_to_neutralization_are_located_at_the_junction_of_the_A_and_B_strands_at_positions_136_and_149&amp;diff=118873"/>
				<updated>2016-11-30T10:27:05Z</updated>
		
		<summary type="html">&lt;p&gt;Fat05spoon: Створена сторінка: Mutations at glycosylation internet sites in the V1 area of CRF01_AE viruses that figure out sensitivity and resistance to neutralization are found at the junct...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Mutations at glycosylation internet sites in the V1 area of CRF01_AE viruses that figure out sensitivity and resistance to neutralization are found at the junction of the A and B [http://www.medchemexpress.com/AN3199.html MCE Chemical AN3199] strands at positions 136 and 149. [eighteen]. In this construction, sequences in the V1/V2 domain are coloured violet and sequences from the V3 area are coloured eco-friendly. Pink balls point out the location of the glycosylation web sites at 136 and 149 identified by swarm analysis and the locations of the N301 and N332 glycosylation websites in the V3 domain necessary for the binding of the PGT121, PGT122, and PGT128 bN-MAbs. (C) Surface diagram of the gp140 trimer derived from the PDB 3J5M structure of Lyumkis et al. [17], displays the place of the glycans at N136, N149, N301, and N332 regarded by neutralizing monoclonal and polyclonal antibodies. In panels C and D, sequences from the V1/V2 domain are shaded violet and sequences from the V3 area are shaded green. The hypervariable connecting peptide in between the A and B strands is shaded cyan. (D) Magnified see of the surface of the gp140 trimer exhibiting the spots of glycosylation internet sites (pink) at N136, N149, N301, and N332 that influence the binding of bNAbs. (E) Alignment of sequences from the CRF01_AE viruses explained in this paper alongside with the HXB2 reference sequence and the sequence of the BG505 Env employed for determination of the 3-dimensional construction of the gp140 trimer [seventeen,eighteen]. The hypervariable location is indicated in cyan. The area of PNGS in the hypervariable domain is indicated in purple. Sequence quantity is provided with reference to the HXB2 sequence and to the numbering of BG505 [eighteen].PNGS at situation 149. We also examined the frequency of PNGS at positions 332 and 334 at the stem of the V3 domain (Desk three). We observed that PNGSs occurred at placement 334 in ninety.four% of CRF01_AE viruses (509/563), while a glycosylation internet site transpired at 332 in only 3.four% of viruses (19/563). Hence most CRF01_AE viruses lacked the N332 glycosylation internet site necessary for the binding of PGT121- and PGT122-like MAbs [22].To far better understand the connection amongst envelope composition and neutralization resistance, we plotted the approximate location of the positions of N136 and N149 onto three-dimensional buildings of envelope proteins that have been solved [17,18,20] (Fig. 5A-5D). Even though the sequences in the hypervariable location between the A and B strands of the proteins crystallized to date are shorter than the V1 and V2 domains of the CRF01_AE viruses described in our research (Fig. 5E), the spots of the C-terminus of the A strand and the N-terminus of the B strand have been pretty [http://www.medchemexpress.com/GW274150.html GW274150] nicely conserved and authorized us to design the relative place of PNGSs adjacent to these landmarks. None of the crystal constructions described to date possessed asparagine at position 149, common among CRF01_AE viruses. With these caveats, our research propose that N136 and N149 arise on reverse finishes of the hypervariable loop that connects the A and B strands (Fig. 5A). We also located that PNGSs at N136 and 149 show up to occur in close spatial proximity to the PNGSs at positions 301 and 332 at the stem of the V3 domain (Fig.&lt;/div&gt;</summary>
		<author><name>Fat05spoon</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Differentiation_was_further_validated_at_the_protein_level_by_immunofluorescent_staining_and_quantification_of_cell_numbers_for_KRT5&amp;diff=118479</id>
		<title>Differentiation was further validated at the protein level by immunofluorescent staining and quantification of cell numbers for KRT5</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Differentiation_was_further_validated_at_the_protein_level_by_immunofluorescent_staining_and_quantification_of_cell_numbers_for_KRT5&amp;diff=118479"/>
				<updated>2016-11-29T13:27:59Z</updated>
		
		<summary type="html">&lt;p&gt;Fat05spoon: Створена сторінка: Differentiation was additional [http://bestofhousemusic.be/members/list5drop/activity/187457/ In the DEKA mutant, the movement of Lys180 aspect chain is compara...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Differentiation was additional [http://bestofhousemusic.be/members/list5drop/activity/187457/ In the DEKA mutant, the movement of Lys180 aspect chain is comparable to the a-program, with the terminal amino team reasonably freely traversing in the SF pore] validated at the protein level by immunofluorescent staining and quantification of cell quantities for KRT5 (basal mobile), MUC5AC (secretory mobile) and SCGB1A1 (secretory mobile). Relative to DMSO taken care of cells, for the two DAPT and DBZ there were significantly (all p&lt;/div&gt;</summary>
		<author><name>Fat05spoon</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=The_Notch_signaling_pathway_contains_multiple_ligands,_receptors_and_downstream_effectors&amp;diff=118463</id>
		<title>The Notch signaling pathway contains multiple ligands, receptors and downstream effectors</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=The_Notch_signaling_pathway_contains_multiple_ligands,_receptors_and_downstream_effectors&amp;diff=118463"/>
				<updated>2016-11-29T12:52:26Z</updated>
		
		<summary type="html">&lt;p&gt;Fat05spoon: The Notch signaling pathway contains multiple ligands, receptors and downstream effectors&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Vectastain Elite ABC kit and AEC substrate kit (Dako North The us Inc., Carpinteria, CA, United states) were utilized to visualize antibody binding and slides were counterstained with Mayer's hematoxylin (Polysciences Inc., Warrington, PA) and mounted using faramount mounting medium (Dako North The usa Inc.). Photos have been acquired using a Nikon Microphot microscope with a Nikon Plan N. A. .70 40 x objective lens and an Olympus DP70 CCD digicam.For sustained activation of Notch signaling in the course of BC differentiation on ALI society, the intracellular domain of the human NOTCH1, two, three and four receptors (NICD1, 2, 3 and four, respectively) had been cloned into a lentiviral expression plasmid. The cDNA template of NICD1 and NICD3 ended up obtained from Addgene (Cat No: 17626 and 26894 respectively, Mountain View, CA, Usa) and the cDNA templates of NICD2 and four had been kindly provided by Dr Warren Pear, College of Pennsylvania, Usa. As soon as NICD1-4 were cloned into pCDH-MSCV-MCS-EF1-GFP, the ensuing plasmids (Lenti-NICD1-four) were sequenced to confirm the proper orientation and integrity of each open up reading body. In addition, expression of every single NICD was confirmed by transfection of 293A cells and subsequent Western analysis with antibodies specific for every single gene. Recombinant replication deficient lentiviruses pseudotyped with the VSVg envelope had been generated by transient co-transfection of 293A cells with Lenti-NICD1-four and the appropriate packaging plasmids. The virus that contains media was gathered at 24 hr intervals with alternative of clean media at every single time point. At seventy two hr submit transfection the media was harvested and pooled with preceding time details for subsequent virus purification by common techniques. The infectious titer of every single virus was determined through GFP positivity pursuing an infection of an immortalized airway basal mobile line (BCi-NS1.1) with serial dilutions of the virus [37].Main BC had been infected with recombinant lentiviruses at an equal multiplicity of infection (MOI) that authorized for equal infectivity among samples as identified by GFP positivity. For an infection of cells on ALI tradition, the virus was additional straight to the cell suspension at the time of seeding the cells on Transwell inserts in the normal ALI media supplemented with 2 g/ml of polybrene to support virus an infection. The following day, the infectious media was taken out and the standard ALI protocol continued as explained previously mentioned.The Mann-Whitney U test was utilized for statistical analyses of all experiments. In all analyses, a p value considerably less than .05 was deemed important.The Notch signaling pathway is made up of numerous ligands, receptors and downstream effectors (Fig. 1A). Microarray analysis of human airway basal cells (BC) exposed expression of the Notch ligands DLL1, DLL4, JAG1 and JAG2, and expression of the four Notch receptors (NOTCH1-4) (Fig. 1B). Nonetheless, the ligand DLL3 was not expressed. Analysis of recognized Notch downstream effectors demonstrated expression of RBPJK, HES1, HES2, HES4, HES5, HES6, HEY1, HEY2 and HEYL, although HES7 was not expressed (Fig. 1C). All round these knowledge show that human airway BC categorical most parts of the Notch signaling pathway.To evaluate the position of Notch signaling in regulation of human airway BC differentiation, BC were cultured below differentiation-inducing air-liquid interface (ALI) problems in the existence of -secretase inhibitors (DAPT or DBZ) that inhibit activation of Notch signaling. Pursuing 28 days of ALI culture, differentiation of BC into secretory and ciliated cells was quantified at the histological amount by Alcian blue staining of ALI working day 28 cross-sections (Fig. 2A). As anticipated, treatment method of cells with the drug motor vehicle DMSO had no important (each p&amp;gt;0.eight) result on the figures of secretory (four.1% untreated vs 4.7% DMSO) and ciliated cells (39.6% untreated vs 42.8% DMSO) relative to untreated cells (Fig. 2B,C).&lt;/div&gt;</summary>
		<author><name>Fat05spoon</name></author>	</entry>

	</feed>